Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trulieve Cannabis Corp C.TRUL

Alternate Symbol(s):  TCNNF | C.TRUL.NT.U

Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Its three regional hubs are anchored by market positions in cornerstone states of Florida, Pennsylvania, and Arizona. The Company operates in regulated markets that require knowledge in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including critical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, the Company owns and utilizes carbon dioxide extraction, distillation, purification and manufacturing technology that is used to produce a range of cannabis topicals and vapes featuring cannabinoids. The Company's brands include premium tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.


CSE:TRUL - Post by User

Post by zack50on Mar 31, 2022 8:53am
266 Views
Post# 34562288

"Buy" rating... TP reduced... Average SP @ $70

"Buy" rating... TP reduced... Average SP @ $70

Echelon Partners’ Andrew Semple reduced his target for shares of Trulieve Cannabis Corp. to $55 from $60, reiteraiting a “buy” rating. Others making changes include: ATB Capital Markets’ Kenric Tyghe to $65 from $70 with an “outperform” rating, Canaccord’s Derek Dley to $65 from $70 with a “buy” rating, Stifel’s Andrew Partheniou to $125 from $135 with a “buy” rating, Alliance Global Partners’ Aaron Grey to $60 from $76 with a “buy” rating and BTIG’s Camilo Lyon to $72 from $62 with a “buy” rating. The average is $70.

“Trulieve Cannabis Corp. announced Q421 results slightly below estimates, but which we view as roughly in line with expectations given the slow quarter for U.S. cannabis,” he said. “The quarter represents the first contribution from the Company’s acquisition of Harvest Health & Recreation Inc. completed on October 1, 2021. Trulieve grew revenues 36 per cent quarter-over-quarter on the back of the acquisition, though adj. EBITDA grew just 3 per cent sequentially on pricing and margin pressures, as well as temporary inefficiencies around closing the transaction.”

<< Previous
Bullboard Posts
Next >>